Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/09/2022 | TENAX THERAPEUTICS, INC. | TENX | Grant | Stock Option (right to buy) | 5k | $0.62 | $3.1k | | 06/09/2022 |
01/03/2022 | Dermata Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 57.9k | $1.88 | $108.8k | | 01/03/2022 |
01/03/2022 | Dermata Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 42.1k | $2.07 | $87.1k | | 01/03/2022 |
01/03/2022 | Dermata Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 4.5k | $2.07 | $9.3k | | 01/03/2022 |
01/03/2022 | Dermata Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 197.6k | $1.88 | $371.5k | | 01/03/2022 |
11/23/2021 | Dermata Therapeutics, Inc. | | Purchase | Common Stock | 20k | $2.40 | $48k | | 11/23/2021 |
08/17/2021 | Dermata Therapeutics, Inc. | | Conversion | Common Stock | 17.9k | $0.00 | $0 | By Allison Taylor Proehl 2020 Irrevocable Trust | 08/16/2021 |
08/17/2021 | Dermata Therapeutics, Inc. | | Conversion | Common Stock | 8.9k | $0.00 | $0 | By Meghan Proehl Wilder 2020 Irrevocable Trust | 08/16/2021 |
08/17/2021 | Dermata Therapeutics, Inc. | | Conversion | Common Stock | 35.8k | $0.00 | $0 | By Sean Michael Proehl 2020 Irrevocable Trust Dated December 18, 2020 | 08/16/2021 |
08/17/2021 | Dermata Therapeutics, Inc. | | Conversion | Common Stock | 361.1k | $0.00 | $0 | By Proehl Investment Ventures LLC | 08/16/2021 |
08/17/2021 | Dermata Therapeutics, Inc. | | Purchase | Warrant to Purchase Common Stock | 142.9k | $7.00 | $1000k | By Proehl Family Trust | 08/16/2021 |
08/17/2021 | Dermata Therapeutics, Inc. | | Conversion | Common Stock | 85.6k | $0.00 | $0 | By Proehl Investment Ventures LLC | 08/16/2021 |
08/17/2021 | Dermata Therapeutics, Inc. | | Purchase | Common Stock | 142.9k | $0.00 | $0 | By Proehl Family Trust | 08/16/2021 |
08/17/2021 | Dermata Therapeutics, Inc. | | Conversion | Series 1d Preferred Stock | 120.5k | $0.00 | $0 | By Allison Taylor Proehl 2020 Irrevocable Trust | 08/16/2021 |
08/17/2021 | Dermata Therapeutics, Inc. | | Conversion | Series 1d Preferred Stock | 60.2k | $0.00 | $0 | By Meghan Proehl Wilder 2020 Irrevocable Trust | 08/16/2021 |
08/17/2021 | Dermata Therapeutics, Inc. | | Conversion | Series 1d Preferred Stock | 241.3k | $0.00 | $0 | By Sean Michael Proehl 2020 Irrevocable Trust Dated December 18, 2020 | 08/16/2021 |
08/17/2021 | Dermata Therapeutics, Inc. | | Conversion | Series 1d Preferred Stock | 2.4M | $0.00 | $0 | By Proehl Investment Ventures LLC | 08/16/2021 |
08/17/2021 | Dermata Therapeutics, Inc. | | Conversion | Series 1a Preferred Stock | 2.3M | $0.00 | $0 | By Proehl Investment Ventures LLC | 08/16/2021 |
08/17/2021 | Dermata Therapeutics, Inc. | | Conversion | Series 1b Preferred Stock | 3.7M | $0.00 | $0 | By Proehl Investment Ventures LLC | 08/16/2021 |
08/17/2021 | Dermata Therapeutics, Inc. | | Conversion | Series 1c Preferred Stock | 25.6M | $0.00 | $0 | By Proehl Investment Ventures LLC | 08/16/2021 |
08/17/2021 | Dermata Therapeutics, Inc. | | Conversion | Series 1 Preferred Stock | 1.8M | $0.00 | $0 | By Proehl Investment Ventures LLC | 08/16/2021 |
08/17/2021 | Dermata Therapeutics, Inc. | | Conversion | Series 1a Warrants | 573.8k | $0.00 | $0 | By Proehl Investment Ventures LLC | 08/16/2021 |
08/17/2021 | Dermata Therapeutics, Inc. | | Conversion | Warrant to Purchase Common Stock | 28k | $20.50 | $573.7k | By Proehl Investment Ventures LLC | 08/16/2021 |
08/17/2021 | Dermata Therapeutics, Inc. | | Conversion | Common Stock | 112k | $0.00 | $0 | By Proehl Investment Ventures LLC | 08/16/2021 |
08/17/2021 | Dermata Therapeutics, Inc. | | Conversion | Common Stock | 181.6k | $0.00 | $0 | By Proehl Investment Ventures LLC | 08/16/2021 |
08/17/2021 | Dermata Therapeutics, Inc. | | Conversion | Common Stock | 1.2M | $0.00 | $0 | By Proehl Investment Ventures LLC | 08/16/2021 |
08/16/2021 | Dermata Therapeutics, Inc. | | Purchase | Common Stock | 10k | $4.96 | $49.6k | By Proehl Family Trust | 08/16/2021 |
06/10/2021 | TENAX THERAPEUTICS, INC. | TENX | Grant | Stock Option (right to buy) | 5k | $2.00 | $10k | | 06/10/2021 |
05/01/2020 | TENAX THERAPEUTICS, INC. | TENX | Grant | Stock Option (right to buy) | 500 | $0.66 | $330 | | 05/01/2020 |
06/27/2019 | SOPHIRIS BIO INC. | SPHS | Grant | | 20k | $0.78 | $15.6k | | 06/27/2019 |
06/27/2018 | SOPHIRIS BIO INC. | SPHS | Grant | | 20k | $2.91 | $58.2k | | 06/27/2018 |
05/01/2018 | TENAX THERAPEUTICS, INC. | TENX | Grant | Stock Option (right to buy) | 500 | $6.23 | $3.1k | | 05/01/2018 |
01/23/2018 | Qualigen Therapeutics, Inc. | RTTR | Grant | Non-qualified Stock Option (Right to Buy) | 30k | $0.34 | $10.2k | | 01/23/2018 |
05/30/2017 | SOPHIRIS BIO INC. | SPHS | Grant | | 20k | $2.44 | $48.8k | | 05/30/2017 |
11/29/2016 | Qualigen Therapeutics, Inc. | RTTR | Grant | Stock Option (2015 Equity Incentive Plan) | 7k | $2.37 | $16.6k | | 11/29/2016 |
|